Genmab A/S
DUS:GE9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
D
|
Deutsche Telekom AG
XMUN:DTE
|
DE |
|
F
|
Freedom Holding Corp
F:DMW2
|
US |
|
A
|
Alaska Air Group Inc
XMUN:ALK
|
US |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
B
|
Booking Holdings Inc
XMUN:PCE1
|
US |
|
R
|
Rheinmetall AG
XMUN:RHM
|
DE |
|
V
|
Vinci SA
DUS:SQU
|
FR |
|
O
|
Omega Healthcare Investors, Inc
LSE:0KBL
|
US |
|
China Petroleum & Chemical Corp
F:CHU
|
CN |
|
S
|
SAP SE
XMUN:SAP
|
DE |
Shareholder Yield
Current shareholder yield for 
GE9 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GE9 Price
Genmab A/S
| Average Annual Return | 0.49% |
| Standard Deviation of Annual Returns | 28.41% |
| Max Drawdown | -64% |
| Market Capitalization | 140B EUR |
| Shares Outstanding | 65 378 830 |
| Percentage of Shares Shorted |
N/A
|
